Listing 3 - Actual negotiations

Indication:

As an adjunct to diet for the treatment of adults with familial chylomicronemia syndrome (FCS) to reduce triglyceride levels.

Indication:

Cystic fibrosis, F508del or responsive CFTR mutation, 6 years and older

Indication:

Friedreich's ataxia

Indication:

Advanced or Metastatic Gastric Cancer or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Indication:

For the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining) breast cancer who have received at least one endocrine therapy in the metastatic setting and are not considered suitable for endocrine therapy as the next line of treatment.

Indication:

Atopic dermatitis

Indication:

For the treatment of progressive familial intrahepatic cholestasis (PFIC) in patients 3 months and older.

Indication:

Insomnia

Indication:

Multiple Indications

Indication:

Hereditary Angioedema